Sorry, you need to enable JavaScript to visit this website.

IBRANCE® (palbociclib) Indications and Usage

1 INDICATIONS AND USAGE

IBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:

  • an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or
  • fulvestrant in patients with disease progression following endocrine therapy.

What's New

No Current Announcements.

Search

Please enter your search term(s) for IBRANCE® capsules